Exploring the pharmacological mechanisms of resibufogenin in castration-resistant prostate cancer via network pharmacology and experimental validation
{{output}}
Background: Resibufogenin (RBG) has shown anti-tumor effects in many cancers, but its role and mechanism in castration-resistant prostate cancer (CRPC) are still unclear. ... ...
